Catalent

Novo completes $16.5bn takeover of Catalent
Pharmaphorum
Thu, 12/19/24 - 10:03 am
Novo Holdings
Catalent
CDMOs
M&A
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say
MSN/Reuters
Sun, 12/15/24 - 10:52 pm
Novo Holdings
M&A
Catalent
With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close
Fierce Pharma
Sun, 12/8/24 - 09:37 pm
Novo Holdings
Catalent
Europe
M&A
CDMOs
Backlash builds against Novo’s Catalent takeover
Pharma Voice
Wed, 10/30/24 - 11:40 am
Novo Holdings
Novo Nordisk
Catalent
M&A
Roche
Roche CEO says Novo's Catalent buyout 'could be a problem' for smaller drugmakers
Fierce Pharma
Wed, 10/23/24 - 10:26 pm
Roche
Novo Holdings
Catalent
CDMOs
M&A
drug manufacturing
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout
Reuters
Mon, 10/21/24 - 09:41 am
Catalent
Alessandro Maselli
Novo Holdings
M&A
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal
Fierce Pharma
Fri, 10/18/24 - 11:26 am
Novo Holdings
Catalent
FTC
M&A
Amid Novo Buy, Catalent Offloads New Jersey Facility to Ardena
BioSpace
Mon, 10/14/24 - 09:46 am
Catalent
CDMOs
drug manufacturing
New Jersey
Ardena
FTC request may signal trouble for Novo/Catalent deal
Pharma Voice
Thu, 05/30/24 - 11:09 am
Novo Holdings
Catalent
FTC
M&A
Biopharma M&A activity jumped 71% in Q1 2024
Medical Marketing and Media
Thu, 05/16/24 - 11:37 am
M&A
Novo Nordisk
Catalent
Gilead Sciences
CymaBay Therapeutics
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx
FTC seeks more information on Novo Nordisk parent-Catalent deal
Reuters
Fri, 05/3/24 - 11:28 am
FTC
Novo Nordisk
Catalent
M&A
FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy
BioSpace
Fri, 04/5/24 - 11:52 am
Novo Nordisk
M&A
Catalent
SEC
Novo Nordisk and Catalent deal: net positive or negative for industry?
Biopharma Reporter
Tue, 02/20/24 - 11:06 am
Novo Nordisk
Catalent
M&A
Wegovy
Ozempic
3 questions hanging over the Novo-Catalent deal
Pharma Voice
Wed, 02/14/24 - 10:55 am
Novo Nordisk
Catalent
drug manufacturing
Ozempic Wegovy
Eli Lilly
As Catalent prepares to join Novo family, CDMO's sales continue to slide
Fierce Pharma
Fri, 02/9/24 - 11:21 am
Catalent
CDMOs
earnings
Novo Nordisk
FDA finds control lapses at Catalent plant being sold to Novo
Reuters
Tue, 02/6/24 - 11:36 pm
FDA
drug manufacturing
regulatory
Novo Nordisk
Catalent
Novo Holdings acquires Catalent in $16.5B deal, aiming to boost Wegovy production as demand soars
Medical Marketing and Media
Mon, 02/5/24 - 11:06 pm
Novo Nordisk
Catalent
drug manufacturing
Wegovy
M&A
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
CNBC
Mon, 02/5/24 - 10:10 am
Novo Nordisk
Catalent
drug manufacturing
M&A
Wegovy
Ozempic
Catalent delays quarterly filing with SEC on $700 mln impairment charge
Reuters
Tue, 11/14/23 - 11:18 am
Catalent
SEC
M&A
Shares of Wegovy Partner Catalent Jump After Striking Deal With Activist Investor Elliott
Investopedia
Wed, 08/30/23 - 10:03 am
Catalent
Wegovy
Novo Nordisk
Elliott Management

Pages